Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review. [electronic resource]
Producer: 20060323Description: 365-70 p. digitalISSN:- 1024-5332
- ABO Blood-Group System
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Child, Preschool
- Cord Blood Stem Cell Transplantation -- methods
- Epstein-Barr Virus Infections -- drug therapy
- Female
- Histocompatibility Testing
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- complications
- Lymphoproliferative Disorders -- drug therapy
- Red-Cell Aplasia, Pure -- drug therapy
- Rituximab
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.